CN102205002B - Traditional Chinese medicine for treating intestinal cancer - Google Patents
Traditional Chinese medicine for treating intestinal cancer Download PDFInfo
- Publication number
- CN102205002B CN102205002B CN2011101385741A CN201110138574A CN102205002B CN 102205002 B CN102205002 B CN 102205002B CN 2011101385741 A CN2011101385741 A CN 2011101385741A CN 201110138574 A CN201110138574 A CN 201110138574A CN 102205002 B CN102205002 B CN 102205002B
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- intestinal cancer
- traditional chinese
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The invention relates to a traditional Chinese medicine for treating intestinal cancer. The traditional Chinese medicine is prepared from the following raw material medicaments in part by weight: 1 to 2 parts of tangerine peel, 1 to 2 parts of Chinese date, 1 to 3 parts of negundo chastetree fruit, 2 to 5 parts of collina and 2 to 5 parts of India madder root. The Chinese medicinal raw materials of the traditional Chinese medicine are reasonably matched and supplement each other to commonly take effects of clearing away the heat and detoxicating, and reducing swelling and easing pain, and control and kill cancer cells so as to treat intestinal cancer substantially; and the traditional Chinese medicine has a good treatment effect.
Description
Technical field
The invention belongs to the technical field of Chinese medicines of treatment intestinal cancer disease, be specifically related to a kind of Chinese medicine of treating intestinal cancer.
Background technology
The Clinical symptoms of early stage intestinal cancer is mainly has blood in stool and the bowl evacuation habit change, and when cancerous protuberance is confined to mucous membrane of rectum, having blood in stool accounts for 85% as unique early symptom, is not often paid attention to by patient unfortunately.Made the anus digital examination at that time; How can touch lump; In, late period the intestinal cancer patient except that general common inappetence, lose weight, the General Symptoms such as anemia, still have defecation frequency to increase, defecation not to the utmost, just cancerous protuberance local excitation symptom such as frequent, the tenesmus of meaning; Cancerous protuberance increases can cause stenosis of bowel, intestinal obstruction sign occurs.
Intestinal cancer like adjacent tissues such as bladder and prostate, causes frequent micturition, urgent micturition and dysuria to the normal surrounding tissue organ of invading in late period.Invade and presacral plexus, sacrum tail and flank pain occur.Rectal cancer can also cause hepatomegaly to metastasis to liver, ascites, jaundice, even performance such as dyscrasia.
Intestinal cancer is divided into following several kinds of situation according to the order of severity:
0 phase: cancer is in early days, and cancerous cell only is present in the innermost layer of intestinal.
The I phase: cancerous cell is invaded a lot of zones of colon enteral wall.
The II phase: cancerous cell has exceeded the intestinal scope, is diffused into perienchyma, but is not diffused into lymph node.
The III phase: cancerous cell has been diffused into peripheral lymph node, but also is not diffused into other position of health.
The IV phase: cancerous cell has been diffused into other position of health.Intestinal cancer is easier to transfer to earlier liver and lung.
The recurrence phase: recurrent colorectal cancer reappears after meaning the cancer healing.Cancerous cell possibly recur on intestinal, also maybe be in other position recurrence of human body.
Summary of the invention
The object of the present invention is to provide the Chinese medicine of the good treatment intestinal cancer of a kind of therapeutic effect.
The present invention adopts following technical scheme:
A kind of Chinese medicine of treating intestinal cancer, process by the crude drug of following parts by weight:
Pericarpium Citri Reticulatae 1-2 part, Fructus Jujubae 1-2 part, Fructus Viticis Cannabifoliae 1-3 part, Pemisetum flaccidum Griseb 2-5 part and Radix Rubiae 2-5 part.
Preferably process: 3 parts in 1 part of Pericarpium Citri Reticulatae, 1 part in Fructus Jujubae, 2 parts of Fructus Viticis Cannabifoliaes, 3 parts of Pemisetum flaccidum Grisebs and Radix Rubiae by the crude drug of following parts by weight.
The present invention is ground into fine powder with each raw materials mix, directly takes, and four times a day, a 2-3 gram takes with brown sugar water.
Radix Rubiae used among the present invention is gathered for the lunar calendar February.
Chinese medicine of the present invention one month was a course of treatment, and general 0 phase, I phase intestinal cancer are cured half a year, and II phase, III phase, IV phase intestinal cancer can obtain curing and control in 1 year.
Among the present invention, Pericarpium Citri Reticulatae, regulating qi-flowing for strengthening spleen, in the accent, dampness is reduced phlegm; Fructus Jujubae, sweet in the mouth, warm in nature, invigorating the spleen and replenishing QI, nourishing blood to tranquillize the mind; Pemisetum flaccidum Griseb, sweet in the mouth, little hardship, property is flat, clearing away heat-damp and promoting diuresis; Fructus Viticis Cannabifoliae, hot little hardship, warm in nature, dispelling pathogenic wind and eliminating phlegm, the therapeutic method to keep the adverse QI flowing downwards, pain relieving; Radix Rubiae, bitter in the mouth, cold in nature, cooling blood for hemostasis, blood stasis dispelling stimulates the menstrual flow.Raw material of Chinese medicine reasonable compatibility of the present invention complements each other, and plays heat-clearing and toxic substances removing altogether, the effect of reducing swelling and alleviating pain, and control and kill cancer cell are fundamentally treated intestinal cancer, and therapeutic effect is good.
The specific embodiment
Embodiment 1
The Chinese medicine of treatment intestinal cancer is processed by the crude drug of following parts by weight: 4 parts in 1.5 parts of Pericarpium Citri Reticulataes, 1.5 parts in Fructus Jujubae, 2 parts of Fructus Viticis Cannabifoliaes, 4 parts of Pemisetum flaccidum Grisebs and Radix Rubiae.
Embodiment 2
The Chinese medicine of treatment intestinal cancer is processed by the crude drug of following parts by weight: 3 parts in 1 part of Pericarpium Citri Reticulatae, 1 part in Fructus Jujubae, 2 parts of Fructus Viticis Cannabifoliaes, 3 parts of Pemisetum flaccidum Grisebs and Radix Rubiae.
Embodiment 3
The Chinese medicine of treatment intestinal cancer is processed by the crude drug of following parts by weight: 5 parts in 2 parts of Pericarpium Citri Reticulataes, 2 parts in Fructus Jujubae, 3 parts of Fructus Viticis Cannabifoliaes, 5 parts of Pemisetum flaccidum Grisebs and Radix Rubiae.
With each raw materials mix, be ground into fine powder during the medication preparation of embodiment 1-3, directly take, four times a day, a 2-3 gram takes with brown sugar water.
Case 1: Tang, woman, 23 years old, the Chen Cun village people of Shengchi County; Hospital was diagnosed as 0 phase of intestinal cancer in 1993, did not see through many places treatments to alleviate that treated in here afterwards, takes the medicine of embodiment 1; Four times on the one, each 2 grams, take half a year after transference cure cure through examination in hospital, recurrence is paid a return visit in the back.
Case 2: Chu, man, 60 years old; Salt people from town, Yiyang County, hospital was diagnosed as the intestinal cancer I phase in 1996, was in hospital and did not see obvious improvement half a year; Treated in here afterwards, takes the medicine of embodiment 2, four times on the one; Each 2.5 grams are taken sx after three months, just continue to take after three months transference cure and cure through examination in hospital.
Case 3, Lee, man, 51 years old, people from Yiyang County; Nineteen ninety-five, hospital was diagnosed as the intestinal cancer II phase, through how tame hospitalize DeGrain, after come here treatment upon somebody's introduction, take the medicine of embodiment 3; Four times on the one, each 3 grams were taken 1 year continuously, and transference cure is cured through examination in hospital.
Case 4: Seedling, man, 55 years old, people from Yiyang County; Hospital was diagnosed as the intestinal cancer I phase in 2000, did not see through treatment for many years and improvement when treat in here, developed into the III phase in 2005; Take the medicine of embodiment 3, four times on the one, each 3 grams; Took continuously 1 year, not diffusion again of cancerous cell on inspection, the state of an illness is controlled.
Drug therapy intestinal cancer patient 140 examples of the present invention are cured 109 examples, 23 examples that take a turn for the better, and 8 examples that do not heal, cure rate reaches 78%.
The intestinal cancer efficacy evaluation:
Cure: transference cure, the inspection cancerous cell disappears.
Take a turn for the better: sx, cancerous cell reduces.
Do not heal: the symptom no change, cancerous cell continues diffusion.
Claims (2)
1. Chinese medicine of treating intestinal cancer, it is characterized in that: the crude drug by following parts by weight is processed:
Pericarpium Citri Reticulatae 1-2 part, Fructus Jujubae 1-2 part, Fructus Viticis Cannabifoliae 1-3 part, Pemisetum flaccidum Griseb 2-5 part and Radix Rubiae 2-5 part.
2. the Chinese medicine of treatment intestinal cancer as claimed in claim 1 is characterized in that: the crude drug by following parts by weight is processed: 3 parts in 1 part of Pericarpium Citri Reticulatae, 1 part in Fructus Jujubae, 2 parts of Fructus Viticis Cannabifoliaes, 3 parts of Pemisetum flaccidum Grisebs and Radix Rubiae.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011101385741A CN102205002B (en) | 2011-05-26 | 2011-05-26 | Traditional Chinese medicine for treating intestinal cancer |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011101385741A CN102205002B (en) | 2011-05-26 | 2011-05-26 | Traditional Chinese medicine for treating intestinal cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102205002A CN102205002A (en) | 2011-10-05 |
| CN102205002B true CN102205002B (en) | 2012-05-23 |
Family
ID=44694245
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2011101385741A Expired - Fee Related CN102205002B (en) | 2011-05-26 | 2011-05-26 | Traditional Chinese medicine for treating intestinal cancer |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102205002B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108567917A (en) * | 2018-05-23 | 2018-09-25 | 杜美丽 | A kind of antitumor Chinese and the toxin expelling therapy that gasifies |
| CN112426478A (en) * | 2020-08-15 | 2021-03-02 | 仲崇允 | Traditional Chinese medicine composition for treating intestinal cancer |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1175440A (en) * | 1997-07-10 | 1998-03-11 | 迟经惠 | Pill for cough, asthma and lung carbuncle |
| CN101195022A (en) * | 2007-12-03 | 2008-06-11 | 门连社 | Chinese medicine prescription for curing tumor |
-
2011
- 2011-05-26 CN CN2011101385741A patent/CN102205002B/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1175440A (en) * | 1997-07-10 | 1998-03-11 | 迟经惠 | Pill for cough, asthma and lung carbuncle |
| CN101195022A (en) * | 2007-12-03 | 2008-06-11 | 门连社 | Chinese medicine prescription for curing tumor |
Non-Patent Citations (1)
| Title |
|---|
| 齐元富等.消化道肿瘤的中医常用治法.<<国医论坛>>.1992,(第4期),19-21. * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102205002A (en) | 2011-10-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101683414A (en) | Drug for treating cancers | |
| CN101062146A (en) | Chinese traditional medicine for treating gastric cancer and bone cancer | |
| CN102205035B (en) | Traditional Chinese medicine for treating gastric cancer | |
| CN102205002B (en) | Traditional Chinese medicine for treating intestinal cancer | |
| CN101036732B (en) | Chinese medicine preparation for esophagus cancer and its compounding process | |
| CN102228504A (en) | Formula of anticancer Chinese medicine and process for preparing products of anticancer Chinese medicine | |
| CN102357215B (en) | Ointment for treating right hypochondriac distention and pain caused by acute and chronic cholecystitis | |
| CN101502561B (en) | Chinese patent medicine for treating bile reflux gastritis as well as gallbladder disease | |
| CN103623291B (en) | Chinese medicine composition of a kind of Therapeutic cancer and preparation method thereof | |
| CN102949613A (en) | Health-care product particle for treating urinary calculus and preparation method thereof | |
| CN101919967B (en) | Traditional Chinese drug for treating esophagus cancer | |
| CN100444871C (en) | Atoxic traditional Chinese medicine composition for treating rheumatosis and rheumatoid disease | |
| CN115317583B (en) | Traditional Chinese medicine composition for gastric cancer postoperative and application thereof | |
| CN101461841B (en) | Chinese patent medicine for treating prostatoplasia | |
| CN101590211B (en) | Pure Chinese medicinal oral preparation for treating psoriasis and preparation method thereof | |
| CN101912463B (en) | Medicament for treating infantile rectocele and preparation method thereof | |
| CN101264268B (en) | Proprietary Chinese medicine for treating tumor | |
| CN101229281B (en) | Medicine for treating rheumatoid arthritis | |
| CN105998958A (en) | Medicine for treating pancreatic cancer and preparation method thereof | |
| CN101332272A (en) | Traditional Chinese medicine formula for treating gastropathy | |
| CN106344718A (en) | Traditional Chinese herbal compound for treating intestinal cancer | |
| CN102688398B (en) | White lilac Chinese medicinal oral liquid for treating jaundice and preparation method thereof | |
| CN102697951B (en) | Cistanche traditional Chinese medicine decoction for treating astriction and preparation method for decoction | |
| CN102580008B (en) | Chinese medicine for treating epigastric pain | |
| CN103623091B (en) | Medicament for external use for treating gout |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120523 Termination date: 20160526 |